Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.

NPJ Breast Cancer · 2020 · PMC7217941 · PMID 32436923

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Risks associated with integration of biomarkers in clinical trials In contemporary clinical research there is an increasing trend toward the use of biomarker results obtained in daily practice to select patients for inclusion in clinical trials.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.